Benchmark Co. Maintains Cross Country Healthcare(CCRN.US) With Hold Rating
Truist Financial Maintains Cross Country Healthcare(CCRN.US) With Hold Rating, Maintains Target Price $18.61
Analysts' Opinions Are Mixed on These Healthcare Stocks: Edgewise Therapeutics (EWTX) and Cross Country Healthcare (CCRN)
UBS Maintains Cross Country Healthcare(CCRN.US) With Hold Rating, Raises Target Price to $18.61
JMP Securities Maintains Cross Country Healthcare(CCRN.US) With Hold Rating
William Blair Maintains Cross Country Healthcare(CCRN.US) With Hold Rating
William Blair Keeps Their Hold Rating on Cross Country Healthcare (CCRN)
William Blair Maintains Cross Country Healthcare(CCRN.US) With Hold Rating
Analysts Offer Insights on Healthcare Companies: Tactile Systems Technology (TCMD) and Cross Country Healthcare (CCRN)
Cross Country Healthcare Analyst Ratings
Cross Country Healthcare (CCRN) Gets a Hold From Truist Financial
Truist Financial Maintains Cross Country Healthcare(CCRN.US) With Hold Rating, Maintains Target Price $18.61
Barrington Downgrades Cross Country Healthcare(CCRN.US) to Hold Rating, Cuts Target Price to $18.61
Hold Rating Recommended for Cross Country Healthcare Amid Acquisition by Aya Healthcare
Truist Securities Maintains Hold on Cross Country Healthcare, Raises Price Target to $18.61
Cross Country Healthcare Analyst Ratings
Jefferies Initiates Cross Country Healthcare(CCRN.US) With Hold Rating, Announces Target Price $12
UBS Maintains Cross Country Healthcare(CCRN.US) With Hold Rating, Cuts Target Price to $14
Cross Country Healthcare Is Maintained at Buy by Benchmark
Cross Country Healthcare Analyst Ratings